Asha Das - Net Worth and Insider Trading
Asha Das Net Worth
The estimated net worth of Asha Das is at least $3,156 dollars as of 2024-06-19. Asha Das is the SVP & Chief Medical Officer of Tocagen Inc and owns about 167 shares of Tocagen Inc (TOCA) stock worth over $3,156. Details can be seen in Asha Das's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Asha Das has not made any transactions after 2017-04-19 and currently still holds the listed stock(s).
Transaction Summary of Asha Das
Asha Das Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Asha Das owns 2 companies in total, including Progenics Pharmaceuticals Inc (PGNX) , and Forte Biosciences Inc (FBRX) .
Click here to see the complete history of Asha Das’s form 4 insider trades.
Insider Ownership Summary of Asha Das
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PGNX | Progenics Pharmaceuticals Inc | 2020-06-19 | Chief Medical Officer |
| FBRX | Forte Biosciences Inc | 2017-04-12 | SVP & Chief Medical Officer |
Asha Das Latest Holdings Summary
Asha Das currently owns a total of 1 stock. Asha Das owns 167 shares of Tocagen Inc (TOCA) as of April 19, 2017, with a value of $3,156.
Latest Holdings of Asha Das
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TOCA | Tocagen Inc | 2017-04-19 | 167 | 18.90 | 3,156 |
Holding Weightings of Asha Das
Asha Das Form 4 Trading Tracker
According to the SEC Form 4 filings, Asha Das has made a total of 0 transactions in Tocagen Inc (TOCA) over the past 5 years. The most-recent trade in Tocagen Inc is the acquisition of 167 shares on April 19, 2017, which cost Asha Das around $25,000.
Insider Trading History of Asha Das
- 1
Asha Das Trading Performance
GuruFocus tracks the stock performance after each of Asha Das's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Asha Das is -26.61%. GuruFocus also compares Asha Das's trading performance to market benchmark return within the same time period. The performance of stocks bought by Asha Das within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Asha Das's insider trading performs compared to the benchmark.
Performance of Asha Das
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.23 | | | | | |
| Relative Return to S&P 500(%) | 10.37 | | | | | |
Asha Das Ownership Network
Asha Das Owned Company Details
What does Progenics Pharmaceuticals Inc do?
Who are the key executives at Progenics Pharmaceuticals Inc?
Asha Das is the Chief Medical Officer of Progenics Pharmaceuticals Inc. Other key executives at Progenics Pharmaceuticals Inc include 10 percent owner & other: See Explanation of Responses Balaji Venkataraman , 10 percent owner & other: See Explanation of Responses Virinder Nohria , and 10 percent owner Broadfin Healthcare Master Fund Ltd .
Progenics Pharmaceuticals Inc (PGNX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Progenics Pharmaceuticals Inc (PGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Progenics Pharmaceuticals Inc (PGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Progenics Pharmaceuticals Inc (PGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Progenics Pharmaceuticals Inc Insider Transactions
Asha Das Mailing Address
Above is the net worth, insider trading, and ownership report for Asha Das. You might contact Asha Das via mailing address: C/o Progenics Pharmaceuticals, Inc., 1 World Trade Center, 47th Fl, Suite J, New York Ny 10007.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
